These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38496964)

  • 1. Targeted Delivery of Gemcitabine for Precision Therapy of Cholangiocarcinoma Using Hyaluronic Acid-Modified Metal-Organic Framework Nanoparticles.
    Long C; Peng H; Yang W; Wang M; Luo B; Hao J; Dong Y; Zuo W
    ACS Omega; 2024 Mar; 9(10):11998-12005. PubMed ID: 38496964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells.
    Fan Q; Zuo J; Tian H; Huang C; Nice EC; Shi Z; Kong Q
    J Exp Clin Cancer Res; 2022 May; 41(1):162. PubMed ID: 35501823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
    Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
    Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
    Zhang R; Ru Y; Gao Y; Li J; Mao S
    Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
    Lu Z; Su J; Li Z; Zhan Y; Ye D
    Drug Dev Ind Pharm; 2017 Jan; 43(1):160-170. PubMed ID: 27553814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy.
    Fan Y; Wang Q; Lin G; Shi Y; Gu Z; Ding T
    Acta Biomater; 2017 Oct; 62():257-272. PubMed ID: 28859899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice
    Dubey RD; Klippstein R; Wang JT; Hodgins N; Mei KC; Sosabowski J; Hider RC; Abbate V; Gupta PN; Al-Jamal KT
    Nanotheranostics; 2017; 1(1):59-79. PubMed ID: 29071179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable Imprinted Polymer Based on ZIF-8/DOX-HA for Synergistically Targeting Prostate Cancer Cells and Controlled Drug Release with Multiple Responses.
    Song Y; Han S; Liu S; Sun R; Zhao L; Yan C
    ACS Appl Mater Interfaces; 2023 May; 15(21):25339-25353. PubMed ID: 37212295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid conjugated multi-walled carbon nanotubes for colon cancer targeting.
    Prajapati SK; Jain A; Shrivastava C; Jain AK
    Int J Biol Macromol; 2019 Feb; 123():691-703. PubMed ID: 30445095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronidase-trigger nanocarriers for targeted delivery of anti-liver cancer compound.
    Xu J; Chen S; Yang J; Nie Z; He J; Zhao Y; Liu X; Zhang J; Zhao Y
    RSC Adv; 2023 Apr; 13(16):11160-11170. PubMed ID: 37056973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 14. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.
    Ma T; Jiang JL; Qi WX; Chen JY; Xu HP
    Drug Des Devel Ther; 2022; 16():2395-2406. PubMed ID: 35923931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy.
    Li J; Chen Y; Zeng L; Lian G; Chen S; Li Y; Yang K; Huang K
    J Biomed Nanotechnol; 2016 Aug; 12(8):1654-66. PubMed ID: 29342344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pH-Responsive CaO
    Li X; Xu M; Geng Z; Xu X; Han X; Chen L; Ji P; Liu Y
    ACS Appl Mater Interfaces; 2023 Sep; 15(36):42965-42980. PubMed ID: 37656022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N; Saharkhiz S; Dini G; Yousefnia S
    Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line.
    Yu X; Di Y; Xie C; Song Y; He H; Li H; Pu X; Lu W; Fu D; Jin C
    Int J Nanomedicine; 2015; 10():6825-34. PubMed ID: 26586944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells.
    Wang JH; Lee EJ; Ji M; Park SM
    Oncol Rep; 2018 Jul; 40(1):346-354. PubMed ID: 29767267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy.
    Obaid EAMS; Wu S; Zhong Y; Yan M; Zhu L; Li B; Wang Y; Wu W; Wang G
    Biomater Sci; 2022 Aug; 10(17):4837-4847. PubMed ID: 35858474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.